Search / Trial NCT06616298

ALIGN for Older Adults With Cancer in SNFs

Launched by UNIVERSITY OF COLORADO, DENVER · Sep 24, 2024

Trial Information

Current as of December 22, 2024

Recruiting

Keywords

Skilled Nursing Facility Caregiver

ClinConnect Summary

The clinical trial titled "ALIGN for Older Adults With Cancer in SNFs" is studying a special type of care called palliative care, which focuses on improving the quality of life for patients with advanced cancer. This trial aims to see if the ALIGN program can be successfully offered to older adults who are transitioning from a hospital to a skilled nursing facility (SNF) in Colorado. The main goals are to determine how well the program can be delivered in different facilities, gather feedback from participants, and help caregivers make important medical decisions when their loved ones can't do so themselves.

To participate, you must be an adult aged 18 or older with advanced solid tumors, and you should be able to speak English. If you join the trial, you’ll meet virtually with a palliative care social worker every 1-2 weeks during your stay at the nursing facility and for up to 45 days after you leave. You will also share updates about your health at 1 month, 3 months, and 6 months after joining. Caregivers you choose can also be part of the study, as long as they meet certain criteria. This trial is currently recruiting participants, so if you think you qualify and are interested, it may be a good opportunity to receive additional support during your cancer journey.

Gender

ALL

Eligibility criteria

  • Patients
  • Inclusion Criteria:
  • 1. Adults between 18-98 years
  • 2. Stage II-IV solid tumors
  • 3. Discharging from an acute care hospital to a SNF in Colorado
  • 4. English speaking
  • 5. Receiving or establishing care at the University of Colorado Cancer Center
  • 6. If a patient lacks capacity, a legal surrogate decision-maker will be approached to provide proxy consent.
  • 7. Must have access to the technology needed to complete consenting visit and subsequent intervention visits. This includes internet access through a computer, tablet, or smartphone OR cellular service with adequate allowance of cellular minutes to allow virtual visits (by participant\'s assessment).
  • Exclusion Criteria:
  • 1. Discharging with hospice care
  • 2. Age less than 18
  • 3. Lacking capacity without a legal surrogate decision maker or proxy. Patient with limited English
  • Caregivers
  • Inclusion Criteria:
  • 1. Patient-selected
  • 2. Age ≥ 18
  • 3. English speaking
  • 4. Able to complete baseline measures.
  • Exclusion Criteria:
  • 1. Discharging with hospice care
  • 2. Age \< 18
  • 3. Caregivers with limited English proficiency will be excluded as ALIGN intervention content and documents have only been validated in an English-speaking population.
  • SNF Staff
  • Inclusion Criteria:
  • 1. One of 25 interdisciplinary clinicians from the 5 most common community SNFs
  • 2. Staff must be employed by on of the 5 most common community SNFs named above. (care managers, social workers, nurses, physical therapists, occupational therapists, advanced practice providers, and physicians)
  • Exclusion Criteria:
  • 1. Not employed by one of the top 5 community SNFs patients were discharged to during the pilot trial
  • PCSW
  • Inclusion Criteria:
  • 1. PCSWs who conducted the ALIGN intervention and consent to an interview

Trial Officials

Sarguni Singh, MD

Principal Investigator

University of Colorado, Denver

About University Of Colorado, Denver

The University of Colorado, Denver, is a leading academic institution dedicated to advancing medical research and improving healthcare outcomes. With a strong emphasis on innovation and collaboration, the university conducts a diverse range of clinical trials aimed at addressing critical health challenges. Its research initiatives are supported by a multidisciplinary team of experts, state-of-the-art facilities, and a commitment to ethical standards and patient safety. By fostering partnerships with local and global communities, the University of Colorado, Denver, strives to translate scientific discoveries into meaningful advancements in clinical practice and public health.

Locations

Aurora, Colorado, United States

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0